John Kapoor, the former billionaire who founded drugmaker Insys Therapeutics, is among the executives to be sentenced for racketeering.Read More
The maker of a highly addictive fentanyl-based drug wants to sell its assets to pay some $250 million in debts. The move could let the company out of part of the settlement deal reached last week.Read More